Open access · OA
via OpenAlex
Diabetic β Cells: To Be or Not To Be?
Cell · 2012 · ▲ 27 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.cell.2012.08.021
- Canonical
- link ↗
- Fetched
- 2026-06-07 MST
Cite this
APA
Puri, S., & Hebrok, M. (2012). Diabetic β Cells: To Be or Not To Be?. <em>Cell</em>. https://doi.org/10.1016/j.cell.2012.08.021
Vancouver
Puri S, Hebrok M. Diabetic β Cells: To Be or Not To Be?. Cell. 2012. doi:10.1016/j.cell.2012.08.021.
BibTeX
@article{sapna2012Diabet,
title = {Diabetic β Cells: To Be or Not To Be?},
author = {Sapna Puri and Matthias Hebrok},
journal = {Cell},
year = {2012},
doi = {10.1016/j.cell.2012.08.021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing Research Reviews 2013
Citation only
Role of SIRT1 and AMPK in mesenchymal stem cells differentiation
Nature Reviews Disease Primers 2019
Open access · OA
Diabetic neuropathy
The EMBO Journal 2011
Open access · OA
Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes
Immunobiology 2018
Preprint · OA
Mesenchymal stromal/stem cells as potential therapy in diabetic retinopathy
Journal of Molecular Medicine 2011
Citation only
SIRT1 is required for long-term growth of human mesenchymal stem cells
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2020
Open access · OA